Quoin Pharmaceuticals, Ltd.QNRX

$4.65+0.03 (+0.65%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$13M

Micro-cap

-97%

2020 — today

10-Year Price

-100%

2016 — today

52-Week Range

$4.20$22.30

Current $4.65· 2%

Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside QRX006, a prospective therapy for an additional rare dermatological ailment. The organization maintains its operational base in Ashburn, Virginia.

Valuation in context

P/E ratio

-0.3

N/A

Not meaningful — company is unprofitable

P/B ratio

1.5

Around average

Around the 10-year average

FCF Yield

-120.5%

Historically low

Historically low relative to the last 10 years

Free · No credit card needed

Get alerted when QNRX is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.